Horn & Co. represented Spacemesh in a Series A $15M financing round led by Polychain Ventures, with participation from the world’s leading blockchain oriented investment funds. The Horn & Co. team was led by Yuval Horn, Ohad Mamann and Maya Weiss Donin. Tomer Afek, Aviv Eyal and Ifat Linur – congratulations on this impressive milestone!
September 6, 2018
Congratulations to our client, IOPtima Ltd., on the completion of the second stage of its acquisition transaction with Chengdu Kanghong Pharma Group Co. Ltd. Horn & Co. team was led by Yuval Horn, Paz Abercohen and Uri Dotan.
September 1, 2018
Proud to lead the list of top Israeli firms specializing in Hi-tech with an equal number of female and male partners, as described in this interesting article by @themarker.
August 8, 2018
Yuval Horn and Keren Kanir of Horn & Co. represented Anima Biotech in an exclusive collaboration agreement with Eli Lilly, with a total deal value exceeding $1 billion.
July 24, 2018
Congratulations to our client, Zebra Medical for closing an impressive $30M financing round led by aMoon Ventures, with participation from Aurum, Johnson & Johnson Innovation and additional new and current investors.
June 10, 2018
Proud to be ranked, again, by IAM Magazine (Intellectual Asset Management) as one of top 4 “highly recommended” Israeli firms in intellectual property transactions: “Horn & Co’s small size belies the reputation it enjoys with regard to the commercialisation of intellectual property.
June 10, 2018
Yuval Horn chosen as “Thought Leader” of Life Sciences Transactions by Who’s Who Legal: Life Sciences 2018.
May 13, 2018
Horn & Co. has been recognized again by Legal 500 as a “Tier 1” firm in Israel in the field of Healthcare and Life Sciences.
April 15, 2018
Yuval Horn and Ohad Mamann of Horn & Co. represented Pontifax, who led a €16 million Series A round and restructuring in ABAC Therapeutics, Inc.
February 27, 2018
Who’s who legal – Data, Data, Data
February 1, 2018
